ZA200902007B - In vivo transformation of pancreatic acinar cells into insulin-producing cells - Google Patents
In vivo transformation of pancreatic acinar cells into insulin-producing cellsInfo
- Publication number
- ZA200902007B ZA200902007B ZA200902007A ZA200902007A ZA200902007B ZA 200902007 B ZA200902007 B ZA 200902007B ZA 200902007 A ZA200902007 A ZA 200902007A ZA 200902007 A ZA200902007 A ZA 200902007A ZA 200902007 B ZA200902007 B ZA 200902007B
- Authority
- ZA
- South Africa
- Prior art keywords
- cells
- insulin
- pancreatic acinar
- vivo transformation
- producing cells
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 230000009466 transformation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84646506P | 2006-09-22 | 2006-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200902007B true ZA200902007B (en) | 2010-03-31 |
Family
ID=39201346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200902007A ZA200902007B (en) | 2006-09-22 | 2009-03-20 | In vivo transformation of pancreatic acinar cells into insulin-producing cells |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080145937A1 (xx) |
EP (1) | EP2082036A4 (xx) |
JP (1) | JP2010504360A (xx) |
KR (1) | KR20090079897A (xx) |
CN (1) | CN101573445A (xx) |
AU (1) | AU2007299649B2 (xx) |
CA (1) | CA2700360A1 (xx) |
IL (1) | IL197713A (xx) |
NZ (1) | NZ575590A (xx) |
WO (1) | WO2008036953A2 (xx) |
ZA (1) | ZA200902007B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013203474B2 (en) * | 2008-11-13 | 2015-08-27 | Baylor Research Institute | Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo |
TW201029669A (en) * | 2008-11-13 | 2010-08-16 | Baylor Res Inst | Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo |
WO2011017107A2 (en) * | 2009-07-27 | 2011-02-10 | Virginia Commonwealth University | Microbubble assisted viral delivery |
AR080029A1 (es) * | 2010-01-27 | 2012-03-07 | Baylor Res Inst | Composicion de microburbujas que comprende un adn plasmidico que codifica un factor de crecimiento del endotelio vascular humano |
CN102140129B (zh) * | 2010-02-03 | 2014-04-23 | 中国农业科学院北京畜牧兽医研究所 | 鸡pdx1多克隆抗体及应用 |
JP2016508509A (ja) * | 2013-02-15 | 2016-03-22 | ザ・ロイヤル・インスティテューション・フォア・ジ・アドヴァンスメント・オブ・ラーニング/マックギル・ユニバーシティThe Royal Institution For The Advancement Of Learning/Mcgill University | 糖尿病を治療するための改変されたingapペプチド |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
AU7506396A (en) * | 1995-11-09 | 1997-05-29 | Takeda Chemical Industries Ltd. | Composition for improving pancreatic function |
US6087129A (en) * | 1996-01-19 | 2000-07-11 | Betagene, Inc. | Recombinant expression of proteins from secretory cell lines |
EP1401282A4 (en) * | 2001-05-25 | 2005-03-30 | Cythera Inc | DIFFERENTIATION OF STEM CELLS |
US20040132679A1 (en) * | 2002-09-03 | 2004-07-08 | Baylor College Of Medicine | Induction of pancreatic islet formation |
JP2006525994A (ja) * | 2003-05-12 | 2006-11-16 | サラ ファーバー, | 非膵島組織における調節された膵ホルモンの産生を誘導する方法 |
-
2007
- 2007-09-21 KR KR1020097008197A patent/KR20090079897A/ko not_active Application Discontinuation
- 2007-09-21 JP JP2009529423A patent/JP2010504360A/ja active Pending
- 2007-09-21 WO PCT/US2007/079242 patent/WO2008036953A2/en active Application Filing
- 2007-09-21 CA CA2700360A patent/CA2700360A1/en not_active Abandoned
- 2007-09-21 NZ NZ575590A patent/NZ575590A/en not_active IP Right Cessation
- 2007-09-21 EP EP07843023A patent/EP2082036A4/en not_active Withdrawn
- 2007-09-21 US US11/859,709 patent/US20080145937A1/en not_active Abandoned
- 2007-09-21 AU AU2007299649A patent/AU2007299649B2/en not_active Ceased
- 2007-09-21 CN CNA2007800434297A patent/CN101573445A/zh active Pending
-
2009
- 2009-03-19 IL IL197713A patent/IL197713A/en not_active IP Right Cessation
- 2009-03-20 ZA ZA200902007A patent/ZA200902007B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010504360A (ja) | 2010-02-12 |
WO2008036953A3 (en) | 2008-10-30 |
IL197713A (en) | 2012-09-24 |
AU2007299649B2 (en) | 2012-11-15 |
IL197713A0 (en) | 2011-08-01 |
US20080145937A1 (en) | 2008-06-19 |
WO2008036953A8 (en) | 2009-07-30 |
KR20090079897A (ko) | 2009-07-22 |
EP2082036A2 (en) | 2009-07-29 |
WO2008036953A2 (en) | 2008-03-27 |
CN101573445A (zh) | 2009-11-04 |
NZ575590A (en) | 2012-03-30 |
AU2007299649A1 (en) | 2008-03-27 |
CA2700360A1 (en) | 2008-03-27 |
EP2082036A4 (en) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267138A (en) | Improved composition of cells and methods for its preparation | |
EP1968622A4 (en) | MICRO-RNA EXPRESSION ANOMALIES IN PANCREAS AND AZINUS TUMORS | |
IL202203B (en) | An artificial bile acid preparation and a method for preparing the acid | |
IL198403A0 (en) | Temporal intraluminal stent, methods of making and using | |
EP2155065A4 (en) | PROCESS FOR THE IMAGE DISPLAY OF CELLS IN VIVO | |
PL2089511T3 (pl) | Rozrost in vitro komórek pochodzących z tkanki pępowinowej wykorzystujących mikronośniki | |
ZA201103044B (en) | Conjugates of glp-1 agonists and uses thereof | |
HRP20190045T1 (hr) | Metode i sastavi za liječenje upalne bolesti crijeva | |
ZA201106299B (en) | Composition comprising caftaric acid and/or derivatives thereof | |
ZA200902007B (en) | In vivo transformation of pancreatic acinar cells into insulin-producing cells | |
HRP20190377T1 (hr) | Uporaba alfa-ketoglutarne kiseline i 5-hidroksi metilfurfurala za smanjenje oksidativnog stresa | |
EP2240571A4 (en) | PREPARATION AND TRANSPLANTATION OF PANCREATIC ISLANDS OF LANGERHANS | |
HK1168793A1 (en) | Glucose metabolism-improving agent and glucose metabolism-improving composition | |
GB0601950D0 (en) | Compositions and methods of treating diabetes | |
GB0608054D0 (en) | Production and use of regulatory t cells | |
EP2147379A4 (en) | COMBINED PERSONAL AND COMMUNITY LISTS | |
EP2113029A4 (en) | IN VIVO GENERAL MUTAGENESIS | |
EP2262488A4 (en) | SOLID COMPLEX OF COLCHICINE; THEIR METHODS OF MANUFACTURE; AND THEIR METHODS OF USE | |
GB0607488D0 (en) | Composition and process | |
GB0605004D0 (en) | Composition and process | |
GB0607493D0 (en) | Composition and process | |
GB0723336D0 (en) | Method of in vitro diagnosing | |
GB0718226D0 (en) | Method of in vitro diagnosing | |
IL195114A0 (en) | Pancreatic islet-like cells | |
ZA200605368B (en) | Gallic acid derivative and process of preparing the same |